Lymphoma, inflammatory bowel disease and immunosuppression – (07-23-01)



Lymphoma, inflammatory bowel disease and immunosuppression

The idea of long term immunosupression to manage a chronic disease has always concerned me. This article reviews the concern, to include the use of the new TNF-alpha receptor blockage medications, of increase risk of lyphoma. Many, if not all, cases of inflammatory bowel disease can respond wonderfully to functional medicine concepts and lifestyle changes. The increased risk of cancer with these therapies that suppress the immune system is opposing Mother Nature, and the downstream effects of this are beyond our current knowledge.

Synergy : Alimentary Pharmacology & Therapeutics 15 (8), 1101-1108

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Inflammatory Bowel Disease
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”